Historique
Auteur L. DEGENHARDT
Documents disponibles écrits par cet auteur (132)
Ajouter le résultat à votre sélection Affiner la recherche
Cannabis is the illicit drug that is most often used by adolescents and the one that young people are most likely to develop dependence on. Cannabis dependence is more common in males, especially those who display disruptive and antisocial behav[...]
ENGLISH : For over two decades, cannabis, commonly known as marijuana, has been the most widely used illicit drug by young people in high-income countries, and has recently become popular on a global scale. Epidemiological research during the [...]
Age differentials in the impacts of reduced heroin: Effects of a "heroin shortage" in NSW, Australia
ENGLISH : Background: This paper uses a unique event, the Australian heroin shortage, to see whether an abrupt, substantial and sustained change in heroin supply had different effects on harms related to heroin use among younger and older hero[...]
C. BHARAT ; P. WEBB ; Z. WILKINSON ; R. McKETIN ; J. GREBELY ; M. FARRELL ; A. HOLLAND ; M. HICKMAN ; L. T. TRAN ; B. CLARK ; A. PEACOCK ; S. DARKE ; J. H. LI ; L. DEGENHARDT | 2023
Dans Addiction (Vol.118, n°9, September 2023) Article : PériodiqueBACKGROUND AND AIMS: Studies often rely upon self-report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self-report instruments. We aimed to examine com[...]
ENGLISH : Aim. To compare relationships between alcohol, cannabis and tobacco and indicators of mental health problems in the general population. Method. A survey of a nationally representative sample of 10 641 Australian adults (the National [...]
C. BREEN ; L. DEGENHARDT ; S. KINNER ; R. BRUNO ; R. JENKINSON ; A. MATTHEWS ; J. NEWMAN | 2006
PériodiqueENGLISH : We examine alcohol use in conjunction with ecstasy use and risk-taking behaviors among regular ecstasy users in every capital city in Australia. Data on drug use and risks were collected in 2004 from a national sample of 852 regular [...]
J. B. SAUNDERS ; L. DEGENHARDT ; G. M. REED ; V. POZNYAK | 2019
Dans Alcoholism: Clinical and Experimental Research (Vol.43, n°8, August 2019) Article : PériodiqueThe Eleventh Revision of the International Classification of Diseases (ICD-11) was formally published in May 2019. Alcohol use disorders form a key part of the section of Disorders due to Substance Use and Addictive Behaviours. This review descr[...]
A. PEACOCK ; L. T. TRAN ; S. LARNEY ; E. STOCKINGS ; T. SANTO ; H. JONES ; D. SANTOMAURO ; L. DEGENHARDT | 2021
Dans Addiction (Vol.116, n°4, April 2021) Article : PériodiqueAIMS: To estimate pooled all-cause and cause-specific mortality risk for people with regular or problematic cocaine use. METHODS: Systematic review and meta-analysis of prospective or retrospective cohort studies or clinical trials (n > = 30) o[...]
J. McGRATH ; J. WELHAM ; J. SCOTT ; D. VARGHESE ; L. DEGENHARDT ; M. R. HAYATBAKHSH ; R. ALATI ; G. M. WILLIAMS ; W. BOR ; J. M. NAJMAN | 2010
PériodiqueContext: Prospective cohort studies have identified an association between cannabis use and later psychosis-related outcomes, but concerns remain about unmeasured confounding variables. The use of sibling pair analysis reduces the influence of u[...]
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY | 2020
Dans Lancet Global Health (The) (Vol.8, n°1, January 2020) Article : PériodiqueBACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]
A. PEACOCK ; J. UPOROVA ; A. KARLSSON ; O. PRICE ; D. GIBBS ; R. SWANTON ; R. CHAN ; R. BRUNO ; P. DIETZE ; S. LENTON ; C. SALOM ; L. DEGENHARDT ; M. FARRELL | 2021
RapportThe Illicit Drug Reporting System (IDRS) is a national illicit drug monitoring system intended to identify emerging trends of local and national concern in illicit drug markets, and forms part of Drug Trends. The IDRS consists of annual intervie[...]
M. DUNN ; L. DEGENHARDT ; G. CAMPBELL ; J. GEORGE ; J. JOHNSTON ; S. KINNER ; A. MATTHEWS ; J. NEWMAN ; N. WHITE | 2007
RapportThe Australian Drug Trends 2006 report presents the findings from the fourth year in which data has been collected in all states and territories in Australia on the markets for ecstasy and related drugs. The Ecstasy and Related Drugs Reporting S[...]
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL | 2023
Dans Lancet Psychiatry (The) (Vol.10, n°6, June 2023) Article : PériodiqueBackground: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]
N. BLACK ; E. STOCKINGS ; G. CAMPBELL ; L. T. TRAN ; D. ZAGIC ; W. D. HALL ; M. FARRELL ; L. DEGENHARDT | 2019
Dans Lancet Psychiatry (The) (Vol.6, n°12, December 2019) Article : PériodiqueBackground: Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain[...]
